Insider Transactions in Q2 2021 at Reneo Pharmaceuticals, Inc. (RPHM)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
20,710
+1.04%
|
$186,390
$9.28 P/Share
|
|
Jun 22
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
14,615
+0.75%
|
$116,920
$8.72 P/Share
|
|
Jun 21
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
32,659
+1.67%
|
$293,931
$9.03 P/Share
|
|
Jun 08
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
16,605
+0.87%
|
$149,445
$9.5 P/Share
|
|
Jun 04
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
257
+0.01%
|
$2,313
$9.42 P/Share
|
|
Jun 03
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
12,100
+0.64%
|
$108,900
$9.25 P/Share
|
|
May 28
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
14
+0.0%
|
$126
$9.5 P/Share
|
|
May 27
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
1,120
+0.06%
|
$10,080
$9.26 P/Share
|
|
May 26
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
5,915
+0.32%
|
$53,235
$9.38 P/Share
|
|
Apr 13
2021
|
Michael G Grey |
BUY
Conversion of derivative security
|
Indirect |
20,162
+4.34%
|
-
|
|
Apr 13
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+9.72%
|
$3,000,000
$15.0 P/Share
|
|
Apr 13
2021
|
Bali Muralidhar Director |
BUY
Conversion of derivative security
|
Indirect |
1,658,226
+50.0%
|
-
|
|
Apr 13
2021
|
Niall O'Donnell Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+8.84%
|
$3,000,000
$15.0 P/Share
|
|
Apr 13
2021
|
Niall O'Donnell Director |
BUY
Conversion of derivative security
|
Indirect |
1,863,713
+40.39%
|
-
|
|
Apr 13
2021
|
New Enterprise Associates 15, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
666,666
+12.23%
|
$9,999,990
$15.0 P/Share
|
|
Apr 13
2021
|
New Enterprise Associates 15, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,118,828
+41.29%
|
-
|
|
Apr 13
2021
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
666,666
+16.27%
|
$9,999,990
$15.0 P/Share
|
|
Apr 13
2021
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,763,711
+50.0%
|
-
|
|
Apr 09
2021
|
River Vest Venture Fund Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+7.67%
|
$3,000,000
$15.0 P/Share
|
|
Apr 09
2021
|
River Vest Venture Fund Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,929,878
+35.83%
|
-
|